Skip to main content

Find Clinical Trials

Home
Conditions
Cystic Fibrosis

Clinical trial condition

Cystic Fibrosis

Explore clinical trials studying Cystic Fibrosis. Study availability and eligibility vary by location and protocol.

1,061 public trials 74 recruiting studies

Refine in advanced search Browse all conditions

Cystic Fibrosis trial results

Completed

Effects of Inhaled Bicarbonate on Airway pH in Cystic Fibrosis

NCT03391414

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
Locations: UPMC Fallk Clinic Pittsburgh, Pennsylvania, United States

Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Canadian Observation Trial in CF Patients Undergoing Treatment With Ivacaftor

NCT03390985

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Breath Analysis in Children by New Point-of-care Instruments

NCT03377686

Conditions: Asthma, Bronchial Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Maastricht University Medical Centre Maastricht, Netherlands

View Trial Details

Completed

PTC124 for the Treatment of Cystic Fibrosis

NCT00351078

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Hadassah University Hospital - Mount Scopus Jerusalem, Israel

View Trial Details

Completed

Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease

NCT02390219

Conditions: Advanced Lung Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, +6 more
Locations: Denver, Colorado, United States

Tampa, Florida, United States

Chicago, Illinois, United States

St Louis, Missouri, United States

View Trial Details

Completed

Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)

NCT00889434

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Hadassah Medical Organization, Mount Scopus Jerusalem, Israel

View Trial Details

Completed

Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis

NCT03357913

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
Locations: Service de médecine interne Centre Hospitalier Lyon Sud, Hospices Civils de Lyon Pierre-Bénite, France

View Trial Details

Completed

Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse Sequences

NCT02449785

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: University Hospital Bordeaux Pessac, France

View Trial Details

Completed

A Study to Evaluate GLPG2222 in Ivacaftor-treated Subjects With Cystic Fibrosis

NCT03045523

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: The Prince Charles Hospital Chermside, Australia

The Alfred Melbourne, Australia

Sir Charles Gairdner Hospital Nedlands, Australia

Westmead Hospital Westmead, Australia

View all 22 locations

View Trial Details

Completed

28 Day Repeat Dose in Cystic Fibrosis Patients

NCT00903201

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Palo Alto, California, United States

GSK Investigational Site Denver, Colorado, United States

View all 33 locations

View Trial Details